Emerging pipeline of protein therapeutics
Results from early in vivo screening assays indicate activity on intestinal cell production in about half of the recombinant proteins and synthetic peptides tested. Epistem is advancing 4 protein therapeutic leads in oncology and GI diseases.
Discovery and development process
Epistem's discovery and development process is based upon the identification of novel targets and leads for tissue regeneration, oncology and GI disease.
